Research Article
COVID-19: A Single-Center ICU Experience of the First Wave in the Philippines
Table 5
Variables and outcomes among non-COVID-19 patients.
| | ICU survivors (n = 45) | ICU nonsurvivors (n = 15) | value (two-tailed) |
| Demographics | | | | Age (years) | 68 (±15) | 57 (±14) | 0.015 | Gender (% of males) | 60% | 80% | 0.218 | SAPS-3 | 47.8 (±12.8) | 58.7 (±20.1) | 0.066 | Comorbidities | | | | Neurologic | | | 0.026 | Yes | 13 (28.9%) | 0 | | No | 32 (71.1%) | 15 (100%) | | Cardiovascular | | | 0.250 | Yes | 39 (86.7%) | 11 (73.3%) | | No | 6 (13.3%) | 4 (26.7%) | | Pulmonary | | | 0.242 | Yes | 16 (35.6%) | 8 (53.3%) | | No | 29 (64.4%) | 7 (46.7%) | | Renal | | | 0.375 | Yes | 22 (48.9%) | 5 (33.3%) | | No | 23 (51.1%) | 10 (66.7%) | | Endocrine | | | 0.552 | Yes | 20 (44.4%) | 5 (33.3%) | | No | 25 (55.6%) | 10 (66.7%) | | Autoimmune | | | 1.000 | Yes | 5 (11.1%) | 2 (13.3%) | | No | 40 (88.9%) | 13 (86.7%) | | Malignancy | | | 0.208 | Yes | 5 (11.1%) | 4 (26.7%) | | No | 40 (88.9%) | 11 (73.3%) | | Laboratories on ICU admission | | | | Hemoglobin (g/L) | 118 (±31) | 126 (±30) | 0.358 | WBC count (×103/µL) | 13.6 (±10) | 11.3 (±7) | 0.328 | Platelets (×109/L) | 226 (±87) | 274 (±157) | 0.275 | PF ratio | 273 (±142) | 203 (±133) | 0.154 | Lactate (mmoL/L) | 2.9 (±2.2) | 2.8 (±1.6) | 0.948 | Treatment strategy | | | | Hydroxychloroquine | | | 0.036 | Yes | 4 (8.9%) | 5 (33.3%) | | No | 41 (91.1%) | 10 (66.7%) | | Tocilizumab | | | 0.059 | Yes | 0 | 2 (13.3%) | | No | 45 (100%) | 13 (86.7%) | | Lopinavir/ritonavir | | | 0.250 | Yes | 0 | 1 (6.7%) | | No | 45 (100%) | 14 (93.3%) | | CRRT | | | 0.250 | Yes | 6 (13.3%) | 4 (26.7%) | | No | 39 (86.7%) | 11 (73.3%) | | NMBA | | | 0.059 | Yes | 0 | 2 (13.3%) | | No | 45 (100%) | 13 (86.7%) | | Prone positioning | | | 0.151 | Yes | 1 (2.2%) | 2 (13.3%) | | No | 44 (97.8%) | 13 (86.7%) | | IVIG | | | — | Yes | 0 | 0 | | No | 45 (100%) | 15 (100%) | | HA-330 | | | — | Yes | 0 | 0 | | No | 45 (100%) | 15 (100%) | | Intubation | | | 0.001 | Yes | 20 (44.4%) | 14 (93.3%) | | No | 25 (55.6%) | 1 (6.7%) | | Others | | | | Number of days intubated | 10 (±7) | 5 (±5) | 0.036 |
|
|